Luteolin: A potential therapeutic agent for respiratory diseases

Area of Science:

• Pharmacology
• Natural Products Chemistry
• Respiratory Medicine

Background:

• Respiratory diseases represent a significant global health burden.
• Naturally derived compounds are gaining attention for therapeutic applications.
• Luteolin (Lut), a flavonoid, exhibits diverse pharmacological activities.

Purpose of the Study:

• To comprehensively review Luteolin's therapeutic effects and mechanisms in respiratory diseases.
• To examine Luteolin's physicochemical properties, toxicity, and action pathways.
• To provide insights for developing Luteolin-based respiratory therapeutics.

Main Methods:

• Literature review of Luteolin's role in respiratory conditions.
• Analysis of Luteolin's pharmacological activities (anti-inflammatory, antioxidative, antineoplastic).
• Examination of molecular pathways targeted by Luteolin.

Main Results:

• Luteolin demonstrates anti-inflammatory, antioxidative, and antineoplastic properties relevant to respiratory diseases.
• Luteolin modulates key signaling pathways including NF-κB, Nrf2, MAPK, JAK/STAT, and PI3K/AKT.
• Luteolin suppresses inflammatory mediators, reduces oxidative stress, and induces apoptosis in lung cancer cells.

Conclusions:

• Luteolin holds significant therapeutic potential for various respiratory conditions.
• Understanding Luteolin's mechanisms can guide the development of novel treatments.
• Further research into Luteolin could lead to new drug development for respiratory ailments.